1. Novel Mannich Bases, 5-Arylimidazolidine-2,4-dione Derivatives with Dual 5-HT1AReceptor and Serotonin Transporter Affinity
- Author
-
Hanna Byrtus, Anna Wesołowska, Maciej Pawłowski, Agata Siwek, Dagmara Wróbel, Marcin Kołaczkowski, Anna Czopek, Adam Bucki, Andrzej J. Bojarski, and Marek Bednarski
- Subjects
Male ,Molecular model ,Stereochemistry ,medicine.drug_class ,Pharmaceutical Science ,Motor Activity ,Ligands ,Anxiolytic ,Mannich Bases ,Mice ,Cricetinae ,Drug Discovery ,medicine ,Animals ,Humans ,Moiety ,Receptor, Serotonin, 5-HT2A ,Receptor ,Swimming ,Serotonin transporter ,5-HT receptor ,Serotonin Plasma Membrane Transport Proteins ,Binding Sites ,Dose-Response Relationship, Drug ,Molecular Structure ,biology ,Chemistry ,Hydantoins ,Ligand (biochemistry) ,Antidepressive Agents ,Rats ,Molecular Docking Simulation ,Anti-Anxiety Agents ,Drug Design ,Receptor, Serotonin, 5-HT1A ,biology.protein ,Computer-Aided Design ,Antidepressant ,Protein Binding - Abstract
A computer aided ligand design study of imidazolidine-2,4-dione derivatives was conducted in order to obtain compounds with dual 5-HT(1A) receptor and serotonin transporter (SERT) affinity. According to molecular modeling results, series of Mannich bases were chosen and synthesized. Investigated compounds were tested for 5-HT(1A) , 5-HT(2A) , α(1) and SERT affinity. Two selected compounds (5, 9) were characterized in functional experiments and possessed a pharmacological profile which may enhance SERT blocking efficacy - 5-HT(1A) partial agonism and 5-HT(2A) antagonism in one molecule. Furthermore these compounds displayed satisfactory selectivity over adrenergic α(1) receptors. The most promising compounds, 5-arylimidazolidine-2,4-dione derivatives with 4-(3-chlorophenyl)piperazinylmethyl moiety were tested for antidepressant and anxiolytic activity. In particular, compound 5 (5-(2-methoxyphenyl)-3-{1-[4-(3-chlorophenyl)piperazin-1-yl]methyl}-imidazolidine-2,4-dione), tested in the forced swim test in mice, exhibited a favorable antidepressant-like profile without affecting spontaneous locomotor activity.
- Published
- 2013
- Full Text
- View/download PDF